RxMen
Latest round
- Seed
Last raised
- Sep 2025
Total raised
- $0.6M
Investors
- 3
About RxMen
Based in New Delhi, India, and founded in 2022, Qurex Health Technologies Private Limited, operates as a health tech startup offering sexual health solutions.A. FAMILY VENTURES LLP and 7Square Ventures. The platform offers comprehensive information on various sexual health issues, including addiction, early discharge, erection issues, painful intimacy, low intimacy drive, and relationship issues, by detecting the signs of sexual challenges, helping to treat them with customized treatments, and monitoring progress, enabling patients to help improve their sexual lives. It also provides customized treatment plans developed by sex therapists and sexologists.
Who invested in RxMen
3 investors across 1 round
See all investors in RxMen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 4, 2025
Amount
$0.6M
Investors
Questions about RxMen
Who invested in RxMen?
RxMen has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RxMen raised?
RxMen has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did RxMen last raise money?
RxMen's most recent round on record is a Seed, in Sep 2025.
What does RxMen do?
Based in New Delhi, India, and founded in 2022, Qurex Health Technologies Private Limited, operates as a health tech startup offering sexual health solutions.
Where is RxMen headquartered?
RxMen is headquartered in Delhi, India.
Which VCs invest in companies like RxMen?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, MPCi, Zijin Venture Capital and Legend Capital back healthcare companies at RxMen's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like RxMen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.